Why the study?
Do multivariable risk models improve the identification of subjects at risk for atrial fibrillation compared to age alone?
Do multivariable risk models improve the identification of subjects at risk for atrial fibrillation compared to age alone?
Multivariable risk models, such as the SAAFE model, significantly improve the identification of patients at high risk for incident atrial fibrillation compared to age-based screening alone.
Multivariable models may better identify incident AF than age in stroke cohorts; leaves open prospective validation before screening use.
Objective Atrial fibrillation can lead to stroke if untreated, and identifying those at higher risk is necessary for cost-effective screening for asymptomatic, paroxysmal atrial fibrillation. Age has been proposed to identify those at risk, but risk models may provide better discrimination. This study compares atrial fibrillation risk models with age for screening for atrial fibrillation. Methods Nine atrial fibrillation risk models were compared using the Atherosclerosis Risk in Communities study (11 373 subjects , 60.0±5.7 years old). A new risk model (Screening for Asymptomatic Atrial Fibrillation Events—SAAFE) was created using data collected in the Monitoring Disparities in Chronic Conditions study (3790 subjects, 58.9±15.3 years old). The primary measure was the fraction of incident atrial fibrillation subjects who should receive treatment due to a high CHA 2 DS 2 -VASc score identified when screening a fixed number equivalent to the age criterion. Secondary measures were the C statistic and net benefit. Results Five risk models were significantly better than age. Age identified 71 (61%) of the subjects at risk for stroke who subsequently developed atrial fibrillation, while the best risk model identified 96 (82%). The newly developed SAAFE model identified 95 (81%), primarily based on age, congestive heart failure and coronary artery disease. Conclusions Use of a risk model increases identification of subjects at risk for atrial fibrillation. One of the best performing models (SAAFE) does not require an ECG for its application, so that it could be used instead of age as a screening criterion without adding to the cost.
No takes yet. Share an insight, caveat, or question.
Linker et al. (2018) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: